Under the guidance of Professor Zhuang Guihua, XJTU doctoral candidate Xie Li from the School of Public Health, completed research on health economic evaluation, targeted at primary hepatic carcinoma. The research proved that antiviral therapy after hepatectomy for patients with liver cancer related to hepatitis B in the early stage will be a cost-effective strategy. The research result was published online in Hepatology, a leading international journal of gastroenterology and Hepatology (impact factor 13.246). It not only provides a scientific basis for the formulation of hepatocellular carcinoma treatment strategies related to hepatitis B in China, but also can be used as reference by other countries.